1.26
+0.01(+0.80%)
Currency In USD
| Previous Close | 1.25 |
| Open | 1.26 |
| Day High | 1.29 |
| Day Low | 1.23 |
| 52-Week High | 2.04 |
| 52-Week Low | 1.19 |
| Volume | 3.76M |
| Average Volume | 5.13M |
| Market Cap | 999.25M |
| PE | -21 |
| EPS | -0.06 |
| Moving Average 50 Days | 1.6 |
| Moving Average 200 Days | 1.55 |
| Change | 0.01 |
If you invested $1000 in OPKO Health, Inc. (OPK) 10 years ago, it would be worth $88.11 as of May 09, 2025 at a share price of $1.26. Whereas If you bought $1000 worth of OPKO Health, Inc. (OPK) shares 5 years ago, it would be worth $527.2 as of May 09, 2025 at a share price of $1.26.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
OPKO Health to Report First Quarter 2025 Financial Results on April 30, 2025
GlobeNewswire Inc.
Apr 17, 2025 12:00 PM GMT
MIAMI, April 17, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) plans to report operating and financial results for the three months ended March 31, 2025 after the close of the U.S. financial markets on Wednesday, April 30, 2025. OPKO’s s
OPKO Health Announces $100 Million Increase to its Existing Share Repurchase Program
GlobeNewswire Inc.
Apr 04, 2025 12:00 PM GMT
MIAMI, April 04, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) today announced that its Board of Directors has authorized an increase of $100 million to the Company’s existing common stock repurchase program, bringing the aggregate capac
OPKO Health and Entera Bio Enter into Collaboration Agreement to Advance Oral GLP-1/Glucagon Tablet Candidate into the Clinic to Treat Obesity and Metabolic Disorders
GlobeNewswire Inc.
Mar 17, 2025 12:00 PM GMT
MIAMI and JERUSALEM, March 17, 2025 (GLOBE NEWSWIRE) -- OPKO Health, Inc. (NASDAQ: OPK) and Entera Bio Ltd. (NASDAQ: ENTX), a leader in the development of oral peptides and proteins replacement therapies, entered into a collaboration and license ag